CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CLDX — Celldex Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,408,048
+$7,105,233 QoQ
Shares Held
655,954
+20.3% QoQ
Ownership
0.835%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 252 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. CLDX ranks #61 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in CLDX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,408,048 | 655,954 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,302,815 | 545,486 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,957,799 | 550,729 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,328,694 | 553,873 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,255,198 | 553,081 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $9,725,568 | 535,844 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $13,755,219 | 544,330 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $18,315,715 | 538,856 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $19,631,695 | 530,443 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $20,952,305 | 499,221 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $16,236,447 | 409,391 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,949,773 | 361,547 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $11,900,234 | 350,729 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $12,475,093 | 346,723 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,521,636 | 348,253 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,487,996 | 337,531 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,911,870 | 330,559 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,471,680 | 336,808 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,677,590 | 328,095 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $17,409,399 | 322,456 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,264,580 | 97,625 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $298,885 | 14,509 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $254,197 | 14,509 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $245,896 | 16,581 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||